SEARCH

SEARCH BY CITATION

References

  • 1
    Bachert C, Van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999;118: 375379.
  • 2
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl. 5):S147S334.
  • 3
    Kanwar S, Johnston B, Kubes P. Leukotriene C4/D4 induces P-selectin and sialyl Lewis(x)-dependent alterations in leukocyte kinetics in vivo. Circ Res 1995;77: 879887.
  • 4
    Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW. Allergen-specific challenge induces intercellular adhesion molecule-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994;150: 16531659.
  • 5
    Vignola AM, Campbell A, Chanez P et al. HLA DR and ICAM 1 expression in asthma and chronic bronchitis. Am Rev Respir Dis 1993;148: 689694.
  • 6
    Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma after bronchial provocation. Am Rev Respir Dis 1989;139: 806817.
  • 7
    Jeffery PK, Wardlaw AJ, Nelson FC et al. Bronchial biopsies in asthma. An ultrastructural quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140: 17451753.
  • 8
    Ciprandi G, Buscaglia S, Pesce G et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96: 971979.
  • 9
    Ricca V, Landi M, Ferrero E et al. Minimal persistent inflammation is also present in patients with pollen allergy. J Allergy Clin Immunol 2000;105: 5463.
  • 10
    Johnstone SL, Pattermore PD, Sanderson G et al. A longitudinal study on the role of viral infections in exacerbations of asthma in school children in the community. Br Med J 1995;310: 12251229.
  • 11
    Johnstone SL, Pattermore PD, Sanderson G et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154: 154660.
  • 12
    Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56: 839847.
  • 13
    Johnstone D, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatr 1968;42: 793797.
  • 14
    Annaesi-Maesani I. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthma. Allergy 1999;54(Suppl. 57):713.
  • 15
    Ciprandi G, Vizzaccaro A, Cirillo I, Crimi P, Canonica G. Increase of asthma and allergic rhinitis prevalence in young Italian men. Int Arch Allergy Immunol 1996;111: 279283.
  • 16
    Settipane G, Settipane RJ, Hagy GW. Long term risk factors for developing asthma and allergic rhinitis: a 23-year follow up study of college students. Allergy Proc 1994;15: 2125.
  • 17
    Anderson HR, Pottier AC, Strachan DP. Asthma from birth to age 23: incidence and relationship to prior and concurrent atopic status. Thorax 1992;47: 537542.
  • 18
    Jenkins MA, Hopper JL, Flander LB et al. The associations between childhood asthma, and atopy, and parental asthma, hay fever and smoking. Paediatr Perinat Epidemiol 1993;7: 6776.
  • 19
    Lombardi C, Passalacqua G, Gargioni S et al. The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years. Respir Med 2001;95: 912.
  • 20
    Passalacqua G, Ciprandi G, Canonica GW. The nose–lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allerg Clin Immunol 2001;1: 713.
  • 21
    Fontanari P, Burnet H, Zatera-Hartmann C, Jammes Y. Changes in airway resistance induced by nasal inhalation of cold, dry or moist air in normal individuals. J Appl Physiol 1996;81: 17391743.
  • 22
    Simons FE. Allergic rhinobronchitis: the asthma–allergic rhinitis link. J Allergy Clin Immunol 1999;104: 534540.
  • 23
    Imada M, Simons FER, Jay FT, Hayglass KT. Antigen-mediated and polyclonal stimulation of human cytokine production elicit qualitatively different patterns of cytokine gene expression. Int Immunol 1995;7: 229237.
  • 24
    Denburg J. Asthma and rhinitis: a systemic disease. In: NeffenH, FabbriL, HolgateST, O'ByrneP, Baena-CagnaniC, editors. Asthma: A Link Between Environment, Immunology, and the Airways. Seattle, WA: Hogrefe and Huber, 1999, 162166.
  • 25
    Milanese M, Crimi E, Scordamaglia A et al. On the functional consequences of bronchial basement membrane thickening. J Appl Physiol 2001;91: 10351040.
  • 26
    Crimi E, Milanese M, Oddera S et al. Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol 2001;91: 10291034.
  • 27
    Okuda M. Functional heterogeneity of airways mast cells. Allergy 1999;54(Suppl. 57):5062.
  • 28
    Bonavia M, Crimi E, Quaglia A, Brusasco V. Comparison of early and late asthmatic response between patients with allergic rhinitis and mild asthma. Eur Respir J 1996;9: 905909.
  • 29
    Corren J, Adinoff AD, Buckmeier AD, Irwin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90: 250256.
  • 30
    Foresi A, Pelucchi A, Gherson G et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98: 274282.
  • 31
    Watson WT, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91: 97101.
  • 32
    Aubier M, Levy J, Clerici C et al. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial responsiveness in patients with rhinitis. Am Rev Respir Dis 1992;146: 122126.
  • 33
    Grant JA, Nicodemus CF, Findlay SR et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized controlled trial. J Allergy Clin Immunol 1995;95: 923932.
  • 34
    Corren J, Harris AG, Aaronson D et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and asthma. J Allergy Clin Immunol 1997;100: 781788.
  • 35
    Roquet A, Dahlen B, Kumlin M et al. Combined antagonism of leukotriene and histamine produces a predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997;155: 18561863.
  • 36
    Meltzer EO, Malmstrom K, Lu S et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo controlled clinical trial. J Allergy Clin Immunol 2000;105: 917922.
  • 37
    ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind randomized placebo controlled trial. Allergy 1998;3: 116124.
  • 38
    World Allergy Organization. Combined allergic rhinitis and asthma syndrome. http://www.worldallergy.org/professional/allergy_update/caras/airwayssynopsis.shtml. Accessed 18 November 2002.
  • 39
    Strachan D, Sibbald B, Weiland S et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8: 161176.
  • 40
    Passalacqua G, Canonica GW. Impact of rhinitis on airway inflammation: biological and therapeutic implications. Respir Res 2001;2: 320323.